Conformational change of adenine nucleotide translocase-1 mediates cisplatin resistance induced by EBV-LMP1
Ontology highlight
ABSTRACT: Adenine nucleotide translocase-1 (ANT1) is an ADP/ATP transporter protein located in the inner mitochondrial membrane. ANT1 is involved not only in the processes of ADP/ATP exchange, but also in the composition of the mitochondrial membrane permeability transition pore (mPTP); and the function of ANT1 is closely related to its own conformational changes. Notably, various viral proteins can interact directly with ANT1 to influence mitochondrial membrane potential by regulating the opening of mPTP, thereby affecting tumor cell fate. The Epstein-Barr virus (EBV) encodes the key tumorigenic protein, latent membrane protein 1 (LMP1), which plays a pivotal role in promoting therapeutic resistance in related tumors. In our study, we identified a novel mechanism for EBV-LMP1-induced alteration of
SUBMITTER: Lin Zhao
PROVIDER: S-SCDT-EMM-2021-14072 | biostudies-other |
REPOSITORIES: biostudies-other
ACCESS DATA